IMRX insider filings

Immuneering Corp — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-16. Screen IMRX transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 3 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Gengos Andrew — Chief Financial Officer11 leg · 25,000 sh · $89,500——
Bogle Grant C. — Director2——1

Recent insider filings — Immuneering Corp

FiledFormInsiderReported transactionsSource
2026-11-164Gengos Andrew — Chief Financial OfficerPurchase (P): 25,000 @ $3.58EDGAR
2026-11-094Bogle Grant C. — DirectorGrant/award (A): 66,700 (derivative) @ $0EDGAR
2026-11-093Bogle Grant C. — DirectorHoldings only — no transactions reportedEDGAR
2026-07-174Gengos Andrew — Chief Financial OfficerGrant/award (A): 650,000 (derivative) @ $0EDGAR
2026-06-244Zeskind Benjamin J. — PRESIDENT AND CEO, DirectorPurchase (P): 2,400 @ $4.56EDGAR
2026-06-164Hall Brett Matthew — CHIEF SCIENTIFIC OFFICERPurchase (P): 6,035 @ $4.15EDGAR
2026-06-114Feinberg Peter — DirectorGrant/award (A): 33,350 (derivative) @ $0EDGAR
2026-06-114KEATING LAURIE — DirectorGrant/award (A): 33,350 (derivative) @ $0EDGAR
2026-06-114HAUSMAN DIANA — DirectorGrant/award (A): 33,350 (derivative) @ $0EDGAR
2026-06-114Schall Thomas J. — DirectorGrant/award (A): 33,350 (derivative) @ $0EDGAR
2026-06-114CARPENTER ROBERT J — DirectorGrant/award (A): 33,350 (derivative) @ $0EDGAR
2026-03-174Neufeld Leah R — CHIEF PEOPLE OFFICERGrant/award (A): 3,628 @ $4.29EDGAR
2026-02-054Bookman Michael — CHIEF LEGAL OFFICER, SECRETARYGrant/award (A): 176,000 (derivative) @ $0EDGAR
2026-02-054Brakewood Harold Eugene — Chief Business OfficerGrant/award (A): 140,000 (derivative) @ $0EDGAR
2026-02-054Hall Brett Matthew — CHIEF SCIENTIFIC OFFICERGrant/award (A): 344,000 (derivative) @ $0EDGAR
2026-02-054Morales Mallory — SVP Finance, CAOGrant/award (A): 140,000 (derivative) @ $0EDGAR
2026-02-054Neufeld Leah R — CHIEF PEOPLE OFFICERGrant/award (A): 140,000 (derivative) @ $0EDGAR
2026-02-054Zeskind Benjamin J. — PRESIDENT AND CEO, DirectorGrant/award (A): 688,000 (derivative) @ $0EDGAR
2026-02-054Matushansky Igor — Chief Medical OfficerGrant/award (A): 140,000 (derivative) @ $0EDGAR
2026-01-214Brakewood Harold Eugene — Chief Business OfficerPurchase (P): 5,250 @ $4.76EDGAR
2026-01-204Schall Thomas J. — DirectorPurchase (P): 21,645 @ $4.67EDGAR
2026-01-164Hall Brett Matthew — CHIEF SCIENTIFIC OFFICERPurchase (P): 2,298 @ $4.57EDGAR
2026-01-154Neufeld Leah R — CHIEF PEOPLE OFFICERPurchase (P): 2,626 @ $4.15EDGAR
2026-01-144Feinberg Peter — DirectorPurchase (P): 20,000 @ $4.35EDGAR
2026-01-024Feinberg Peter — DirectorGrant/award (A): 7,888 (derivative) @ $0EDGAR
2026-01-024KEATING LAURIE — DirectorGrant/award (A): 7,888 (derivative) @ $0EDGAR
2025-10-074Feinberg Peter — DirectorPurchase (P): 7,500 @ $6.67EDGAR
2025-10-024Morales Mallory — Chief Accounting OfficerPurchase (P): 300 @ $6.39EDGAR
2025-10-024Neufeld Leah R — CHIEF PEOPLE OFFICERPurchase (P): 800 @ $6.38EDGAR
2025-10-024Bookman Michael — CHIEF LEGAL OFFICER, SECRETARYPurchase (P): 1,020 @ $6.83EDGAR
2025-10-014Feinberg Peter — DirectorPurchase (P): 7,500 @ $7.03EDGAR
2025-09-304Feinberg Peter — DirectorPurchase (P): 5,000 @ $7.18EDGAR
2025-09-174Neufeld Leah R — CHIEF PEOPLE OFFICERGrant/award (A): 11,815 @ $1.43EDGAR
2025-09-174Morales Mallory — Chief Accounting OfficerGrant/award (A): 14,497 @ $1.43EDGAR
2025-09-174Hall Brett Matthew — CHIEF SCIENTIFIC OFFICERGrant/award (A): 14,880 @ $1.43EDGAR
2025-07-074Neufeld Leah R — CHIEF PEOPLE OFFICERPurchase (P): 700 @ $3.57EDGAR
2025-07-074HAUSMAN DIANA — DirectorPurchase (P): 2,500 @ $3.60 · Purchase (P): 3,000 @ $3.62EDGAR
2025-07-034Zeskind Benjamin J. — PRESIDENT AND CEO, Director, 10% ownerPurchase (P): 2,985 @ $3.38 · Purchase (P): 7,015 @ $3.53EDGAR
2025-06-304Schall Thomas J. — DirectorPurchase (P): 9,500 @ $3.66EDGAR
2025-06-244Hall Brett Matthew — CHIEF SCIENTIFIC OFFICERPurchase (P): 7,415 @ $2.70 · Purchase (P): 6,007 @ $2.43EDGAR
2025-06-244Brakewood Harold Eugene — Chief Business OfficerPurchase (P): 1,900 @ $2.53EDGAR
2025-06-234Feinberg Peter — DirectorPurchase (P): 25,000 @ $2.53EDGAR
2025-06-204Zeskind Benjamin J. — PRESIDENT AND CEO, Director, 10% ownerPurchase (P): 21,000 @ $2.39EDGAR
2025-06-184Schall Thomas J. — DirectorPurchase (P): 40,485 @ $2.21EDGAR
2025-06-164Feinberg Peter — DirectorGrant/award (A): 33,350 (derivative) @ $0EDGAR
2025-06-164KEATING LAURIE — DirectorGrant/award (A): 33,350 (derivative) @ $0EDGAR
2025-06-164HAUSMAN DIANA — DirectorGrant/award (A): 33,350 (derivative) @ $0EDGAR
2025-06-164Schall Thomas J. — DirectorGrant/award (A): 33,350 (derivative) @ $0EDGAR
2025-06-164BERMAN ANN E — DirectorGrant/award (A): 33,350 (derivative) @ $0EDGAR
2025-06-164CARPENTER ROBERT J — DirectorGrant/award (A): 33,350 (derivative) @ $0EDGAR

Recent 8-K events — Immuneering Corp

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-098-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-10-298-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-058-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-158-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-06-118-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-06-018-K8.01 — Other EventsEDGAR
2026-05-158-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-068-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-01-078-K8.01 — Other EventsEDGAR
2025-11-128-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=IMRX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs